Journal of Clinical and Aesthetic Dermatology

MAY 2018

An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology

Issue link: https://jcadonline.epubxp.com/i/979610

Contents of this Issue

Navigation

Page 19 of 55

20 JCAD JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY May 2018 • Volume 11 • Number 5 O R I G I N A L R E S E A R C H REFERENCES 1. Leto MGP, Santos Jr GF, Porro AM, Tomimori J. Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations. An Bras Dermatol. 2011;86(2): 306–317. 2. Antonsson A, Forslund O, Ekberg H, et al. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of theses viruses. J Virol. 2000;74(24):11636–11641. 3. de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology. 2004;324(1):17–27. 4. Bruggink SC, de Koning MN, Gusseklooa J, et al. Cutaneous wart-associated HPV types: prevalence and relation with patient characteristics. J Clin Virol. 2012;55(3): 250–255. 5. Berman A, Winkelmann RK. Involuting common warts. J Am Acad Dermatol. 1980;3(4):356–362. 6. Bacelieri R, Johnson SM. Cutaneous warts: an evidence-based approach to therapy. Am Fam Physician. 2005; 72(4):647–652. 7. Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006;4(4): 273–293. 8. Leung L. Recalcitrant nongenital warts. Aust Fam Physician. 2011 Jan-Feb; 40(1-2):40-2. 9. Goncalves MA, Donadi EA. Immune cellular response to HPV: current concepts. Braz J Infect Dis. 2004;8(1):1–9 10. Shepherd PS, Hebert A. Tcell responses to HPV in cervical dysplasia. Papillomavir Rep. 1999;10:53–78. 11. Grassegger A, Rollinger-Holzinger I, Zelger BW, et al. Spontaneous or interferon-γ induced Tcell infiltration, HLA-DR and ICAM1 expression in genitoanal warts are associated with TH1 or mixed TH1/TH2 cytokine mRNA expression profiles. Arch Dermatol Res. 1997;289(5):243–250. 12. Dall'oglio F, D'Amico V, Nasca MR, Micali G. Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2012;13(2):73–96. 13. Horn TD, Johnson SM, Helm RM, Roberson PK. Intralesional immunotherapy of warts with mumps, Candida and trichophyton skin test antigens: a single-blinded, randomized and controlled trial. Arch Dermatol. 2005;141(5):589–594. 14. Nofal A, Nofal E. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol. Venereol 2010;24(10): 1166–1170. 15. Zamanian A, Mobasher P, Jazi GA. Efficacy of intralesional injection of mumps-measles- rubella vaccine in patients with wart. Adv Biomedic Res. 2014;3:107. 16. Saini P, Mittal A, Gupta LK, Khare AK, Mehta S. Intralesional mumps, measles and rubella vaccine in the treatment of cutaneous warts. Indian J Dermatol. Venereol Leprol. 2016;82(3):343–345. 17. Singh S, Chouhan K, Gupta S. Intralesional immunotherapy with killed Mycobacterium indicus pranii vaccine for the treatment of extensive cutaneous warts . Indian J Dermatol Venereol Leprol. 2014;80(6):509–514. 18. Dhakar AK, Dogra S, Vinay K, et al. Intralesional Mycobacterium w vaccine versus cryotherapy in treatment of refractory extragenital warts: a randomized, open label, comparative study. J Cutan Med Surg 2016;20(2):123–129. 19. Johnson SM, Roberson PK, Horn TD. Intralesional injection of mumps or candida skin test antigens: a novel immunotherapy for warts. Arch Dermatol. 2001;137(4): 451–455. 20. Johnson SM, Horn TD. Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy. J Drugs Dermatol. 2004;3(3):263–265. JCAD

Articles in this issue

Archives of this issue

view archives of Journal of Clinical and Aesthetic Dermatology - MAY 2018